MedTrace Logo

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

NCT04574596 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-07-27

No results posted yet for this study

Summary

This is a prospective, observational, multicenter, case-control study.

Conditions

  • E Coli Infection

Interventions

OTHER

no Intervention

This is an observational study. There is no intervention

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • Vance G. Fowler, MD · Duke Clinical Research Institute

  • David van Duin, MD, PhD · University of North Carolina

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-12
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04574596 on ClinicalTrials.gov